Advances in cancer neuroscience and drug discovery could benefit patients with Alzheimer’s disease
MD Anderson is known for its cancer care and research. But did you know that for more than a decade, MD Anderson researchers have been working on better treatments for Alzheimer’s disease and other age-related neurodegenerative diseases, too?
Launched in 2012 through a $25 million gift from Robert Belfer and the Belfer family, the Belfer Neurodegeneration Consortium (BNDC) is a multi-institutional initiative between MD Anderson...